Search
for
Sort by
Research 30 of 776
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom
- Neuropsychiatric Systemic Lupus Erythematosus Presenting as Bipolar I Disorder With Catatonic Features
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- LP-155 Psychosis as an early manifestation of neuropsychiatric systemic lupus erythematosus – a case report
- Psychotropic Medication and Drug-Related Alopecia
- Finasteride-Induced Neuropsychiatric Reactions
- Medication Repurposing: New Uses for Old Drugs
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Commonly prescribed medications associated with alopecia
- Finasteride-Induced Neuropsychiatric Reactions
- Agitation as a Paradoxical Effect of Divalproex Sodium: A Case Report
- Health consequences of anabolic steroids: a sexual-medicine perspective
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- General Dermatology
- Neuroimaging of sleep and depression
- Chronic Alopecia
- Drug-induced acne
- Agitation as a Paradoxical Effect of Divalproex Sodium: A Case Report
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Reframing the Discussion on Finasteride and Neuropsychiatric Safety
- P51 Neuropsychiatric lupus, two sides of the same coin
- Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Advancements in Drug Repurposing: Examples in Psychiatric Medications